PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,238 | +30.7% | 22,783 | +28.1% | 0.06% | -3.4% |
| Q4 2022 | $145,514 | +131.0% | 17,789 | +25.5% | 0.06% | +87.1% |
| Q2 2022 | $63,000 | -40.6% | 14,173 | -5.5% | 0.03% | -39.2% |
| Q2 2016 | $106,000 | -55.3% | 15,000 | -46.2% | 0.05% | -67.7% |
| Q1 2016 | $237,000 | – | 27,900 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |